Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongbo Lin

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical Laboratory Analysis|July 17, 2020
A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patientsRongbo Lin, Shen Zhao, Liyu Su, et al.
Computational and Structural Biotechnology Journal|October 2, 2020
Analysis of the expression, function, prognosis and co-expression genes of DDX20 in gastric cancerQingshui Wang, Yan Ye, Rongbo Lin, et al.
Annals of Translational Medicine|November 12, 2020
Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory studyShen Zhao, Nanfeng Fan, Hui Li, et al.
Journal of Chemotherapy (Florence, Italy)|June 27, 2014
A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancerRongbo Lin, Nanfeng Fan, Guangfeng Wu, et al.
Epilepsy Research|November 4, 2022
Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complexXia Zhao, Dian Jiang, Zhanqi Hu, et al.
Epilepsy Research|January 19, 2023
Corrigendum to "Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complex" [Epilepsy Research 188 (2022) 107040, 1-8]Xia Zhao, Dian Jiang, Zhanqi Hu, et al.
Cancer Science|February 14, 2024
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancerShen Zhao, LiYu Su, Feng Huang, et al.
Scientific Reports|February 10, 2026
Parameter-efficient convolutional neural network for drug treatment outcome studies of pediatric epilepsyCailei Zhao, Zhao Liao, Dian Jiang, et al.
Pediatric Neurology|June 23, 2026
Research of Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) in ChinaFei Zheng, Tian Yu, Isah Salim Ahmad, et al.
Quantitative Imaging in Medicine and Surgery|April 13, 2026
Foundation models for X-ray interpretation: a narrative review of current techniques and future perspectives in diagnostic imagingIsah Salim Ahmad, Rabiatu Bako Suleiman, Tian Yu, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Laboratory Analysis|July 17, 2020
A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patientsRongbo Lin, Shen Zhao, Liyu Su, et al.
Computational and Structural Biotechnology Journal|October 2, 2020
Analysis of the expression, function, prognosis and co-expression genes of DDX20 in gastric cancerQingshui Wang, Yan Ye, Rongbo Lin, et al.
Annals of Translational Medicine|November 12, 2020
Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory studyShen Zhao, Nanfeng Fan, Hui Li, et al.
Journal of Chemotherapy (Florence, Italy)|June 27, 2014
A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancerRongbo Lin, Nanfeng Fan, Guangfeng Wu, et al.
Epilepsy Research|November 4, 2022
Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complexXia Zhao, Dian Jiang, Zhanqi Hu, et al.
Epilepsy Research|January 19, 2023
Corrigendum to "Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complex" [Epilepsy Research 188 (2022) 107040, 1-8]Xia Zhao, Dian Jiang, Zhanqi Hu, et al.
Cancer Science|February 14, 2024
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancerShen Zhao, LiYu Su, Feng Huang, et al.
Scientific Reports|February 10, 2026
Parameter-efficient convolutional neural network for drug treatment outcome studies of pediatric epilepsyCailei Zhao, Zhao Liao, Dian Jiang, et al.
Pediatric Neurology|June 23, 2026
Research of Tuberous Sclerosis Complex (TSC)-Associated Neuropsychiatric Disorders (TAND) in ChinaFei Zheng, Tian Yu, Isah Salim Ahmad, et al.
Quantitative Imaging in Medicine and Surgery|April 13, 2026
Foundation models for X-ray interpretation: a narrative review of current techniques and future perspectives in diagnostic imagingIsah Salim Ahmad, Rabiatu Bako Suleiman, Tian Yu, et al.
Pageof 5